Skip to content

PEGATRIM

Active
KBO/BCE: BE 0472.069.702
Watch Print / PDF
Age26 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of PEGATRIM is 0.3% (very low). The 2025 annual accounts show equity of €11.69M and a net result of €-442k. Equity remains stable across the filed fiscal years (±2.1% per year). Its solvency ranks better than 89% of 205 sector peers (fiscal year 2025). The company has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 8 annual accounts.

Signals

2 signals · with evidence
Persistent losses
Two consecutive loss-making years (2024 and 2025); equity fell accordingly. May indicate structural pressure on profitability.
View the result trend
Strong solvency vs sector
Solvency is in the sector's strongest quartile: better than 89% of 205 peers (2025). A comfortable equity buffer.
View the sector comparison

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Trust signals

2 signals
Long-established
Founded in 2000, 26 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.3% Very low
0%0,5%1,5%4%10%≥25%
Higher-failure-rate region +Lower-failure-rate sector Long track record

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

Turnover€1.36M+10.4%
EBIT margin-10.5%+1.3pp
Net result€-442k+20.9%
Working capital€2.33M-0.8%

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 10-04-2026 with the NBB · fiscal year 2025 · volledig
€-1.00M€-500k€0€500k€1.00M€1.50MRevenue 2021: €1.23M€1.23MOperating result 2021: €-145k€-145kNet result 2021: €-165k€-165kRevenue 2022: €1.36M€1.36MOperating result 2022: €-142k€-142kNet result 2022: €-233k€-233kOperating result 2023: €-205k€-205kNet result 2023: €-182k€-182kOperating result 2024: €-576k€-576kNet result 2024: €-559k€-559kOperating result 2025: €-451k€-451kNet result 2025: €-442k€-442k20212022202320242025
RevenueOperating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
stable Equity: stable across 8 fiscal years (±2.1%/year).
€0€5.00M€10.00M€15.00M2026: €11.71M (€10.77M - €12.64M)2027: €11.44M (€10.51M - €12.38M)2028: €11.18M (€10.25M - €12.12M)2018: €493k2019: €13.40M2020: €13.51M2021: €13.34M2022: €12.87M2023: €12.69M2024: €12.13M2025: €11.69M20182019202020212022202320242025202620272028
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 68, Real estate activities · compared within the same schema type (full schema)
Metric This company Sector median Position in the sector
Solvency 94.8% 31.0%
better than 89% of 205 sector peers
Net result €-442k €9k
better than 7% of 204 sector peers
Equity €11.69M €503k
better than 84% of 205 sector peers
Gross operating margin €783k €78k
better than 90% of 144 sector peers
Employees (FTE) 0.0 1.3
better than 20% of 49 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P89
2023: P93 · n=6562024: P93 · n=7762025: P89 · n=2052023 2025
Stable position over 2023-2025 · n=205-776
Net result P7
2023: P13 · n=6522024: P7 · n=7742025: P7 · n=2042023 2025
Stable position over 2023-2025 · n=204-774
Equity P84
2023: P91 · n=6562024: P92 · n=7762025: P84 · n=2052023 2025
Stable position over 2023-2025 · n=205-776
Gross operating margin P90
2023: P95 · n=4982024: P88 · n=6092025: P90 · n=1442023 2025
Stable position over 2023-2025 · n=144-609
Describes the position versus peers, not a forecast.
Revenue
€1.36M
+10.4% 18-25
EBITDA
€585k
+46.4% far above sector median
Net profit
€-442k
+20.9% far below sector median
Cash flow
€594k
+42.7% far above sector median
Total assets
€12.32M
-3.6% far above sector median
Equity
€11.69M
-3.6% far above sector median
Working capital
€2.33M
-0.8% far above sector median
Employees (FTE)
0
- -100% vs sector
Income taxes
€0
- -100% vs sector
Dividends
€0
-100.0% 18-25
Debt
€635k
-3.5% -37% vs sector
Debt ≤ 1y
€259k
-6.1% -48% vs sector
Current ratio
9.98
+5.1% far above sector median
Quick ratio
9.98
+5.1% far above sector median
Solvency
94.8%
0.0% +122% vs sector
Debt / equity
0.05
+0.2% -97% vs sector
ROE
-3.8%
+18.0% -115% vs sector
ROA
-3.6%
+18.0% far below sector median
Net margin
-17.1%
-27.9% 18-25
EBITDA margin
53.1%
+4.4% 18-25
Interest coverage
357.97
+184.6% far above sector median
Figures by fiscal year
Fiscal year2025
Revenue-
EBITDA€585k
Net profit€-442k
Cash flow€594k
Staff costs-
Income taxes€0
Dividends-
Total assets€12.32M
Equity€11.69M
Debt€635k
of which ≤ 1y€259k
of which > 1y-
Working capital€2.33M
Employees (FTE)0.0
Ratios (computed)
2025
Current ratio9.98
Quick ratio9.98
Working capital ratio18.9%
Solvency94.8%
Debt / equity0.05
Long-term debt ratio-
Interest coverage357.97
Gross margin-
Net margin-
ROA-3.6%
ROE-3.8%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€12.32M
Fixed assets 21/28€9.74M
Tangible fixed assets 22/27€9.58M
Financial fixed assets 28€158k
Current assets 29/58€2.59M
Amounts receivable within one year 40/41€192k
Investments 50/53€735k
Cash & bank 54/58€261k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€12.32M
Equity 10/15€11.69M
Contributions / capital 10/11€12.81M
Reserves 13€56k
Accumulated profits (losses) 14€-1.18M
Amounts payable 17/49€635k
Amounts payable within one year 42/48€259k
Trade debts payable within one year 44€165k
Income statement
Gross operating margin 9900€783k
Operating result 9901€-451k
Financial income 75€10k
Financial charges 65€2k
Result before taxes 9903€-442k
Income taxes 67/77€0
Net result for the period 9904€-442k
Result to be appropriated 9905€-442k
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
78 / 100 Excellent
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

1 location
Louizalaan 65, 1050 Elsene
projectontwikkeling voor de nieuwbouw van individuele woningen of voor renovatiewerken
since 20002.115.827.643
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area2,710 m²
Buildings2
Building footprint3,233 m²
Volume (LiDAR)80,866 m³
Tallest building44.0 m · ±9 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21807G0007/00R000 Brussels 1,683 m² 1 · 2,433 m² 35.6 m · 9 fl.
21805E0534/00D000 Brussels 1,027 m² 1 · 800 m² 44.0 m · 8 fl.
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

16 acts
Address history · 1
27-06-2019
Registered-office move
All acts · 16 updated 1 year ago
2025
15-07-2025 6 directors appointed Director changes
  • EY REVISEURS D'ENTREPRISES SRL, Commissaire
  • João Nuno Dos Santos Silva Madeira De Andrade, Administrateur a
  • Miguel José França de Santana, Administrateur a
  • Christophe Tans, Administrateur b
  • Irene Florescu, Administrateur b
  • Pauline Meganck, Administrateur b
Summary: v3.2
2023
13-06-2023 1 director appointed, 1 resigning Director changes
  • Pauline Meganck, Bestuurder
  • Brecht Guldemont, Bestuurder
Summary: v3.2
2022
12-05-2022 6 directors appointed Director changes
  • Joeri Klaykens, Auditor
  • Miguel José França de Santana, Administrator a
  • João Nuno Dos Santos Silva Madeira De Andrade, Administrator a
  • Christophe Tans, Administrator b
  • Irene Florescu, Administrator b
  • Brecht Guidemont, Administrator b
Summary: v3.2
2020
11-05-2020 2 directors appointed Director changes
  • Christophe Tans, Mandataire
  • Irene Florescu, Mandataire
Summary: v3.2
2019
07-11-2019 5 directors appointed Director changes
  • Miguel José França de Santana, Administrateur a
  • João Nuno dos Santos Silva Madeira de Andrade, Administrateur a
  • Christophe Eric Tans, Administrateur b
  • Irene Gabriela Florescu, Administrateur b
  • Brecht Guldemont, Administrateur b
Summary: v3.2
23-08-2019 1 director appointed, 1 resigning Director changes
  • Miguel José FRANÇA DE SANTANA, Zaakvoerder
  • André GOMES DE SOUSA, Zaakvoerder
Summary: v3.2
25-07-2019 1 director appointed, 1 resigning Director changes
  • Joeri Klaykens, Commissaris
  • Kathleen De Brabander, Commissaris
Summary: v3.2
27-06-2019 Registered office moved from Ixelles to Bruxelles Registered-office change·Susana Gonzalez Melon
  • Avenue Louise 65, 1050 Ixelles → 1000 Bruxelles, Belgique, Rue Royale 97, 4ème étage
Notary: Susana Gonzalez Melon · BruxellesFirm: Allen & Overy (Belgium) LLP
11-04-2019 5 directors appointed, 1 resigning Director changes
  • João Andrade, Gérant
  • André Sousa, Gérant
  • Christophe Tans, Gérant
  • Irene Florescu, Gérant
  • Brecht Guldemont, Gérant
  • Quentin Orion, Gérant
Summary: v3.2
2017
19-07-2017 1 director appointed, 1 resigning Director changes
  • Quentin Orion, Zaakvoerder
  • John Hopkins, Zaakvoerder
Summary: v3.2
2016
30-08-2016 Deloitte Bedrijfrevisoren BC ovve CVBA appointed as statutory auditor Director changes
  • Deloitte Bedrijfrevisoren BC ovve CVBA, Commissaris
Summary: v3.2
2015
17-12-2015 Anne Delord resigns as gérante Director changes
  • Anne Delord, Gérante
Summary: v3.2
22-10-2015 John Hopkins appointed as gérant Director changes
  • John Hopkins, Gérant
Summary: v3.2
2010
17-02-2010 4 directors appointed, 2 resigning Director changes
  • Régis PANISI, Bijzondere volmacht
  • Marcos LAMIN-BUSSCHOTS, Bijzondere volmacht
  • Sabrina VARSALONA, Bijzondere volmacht
  • Froukje BEEKMANS, Bijzondere volmacht
  • Noel Ccessens, Bijzondere volmacht
  • Christoffel De Wite, Bijzondere volmacht
Summary: v3.2
2006
13-11-2006 1 director appointed, 1 resigning Director changes
  • Nathalie De Swaef, Commissaris
  • Alain Fiset, Commissaris
Summary: v3.2
2002
07-10-2002 1 director appointed, 1 resigning Director changes
  • R.D. Kingston, Bestuurder
  • D.E.F. Simons, Bestuurder
Summary: v3.2

Analysis

Snowflake analysis

financial profile on 5 axes
Health78Profitability0Solvency100Growth38Stability100
63 / 100

Strong profile, led by solvency.

All 5 axes are computed from data Checked has read.

Health 78
Profitability 0
Solvency 100
Growth 38
Stability 100

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, nearest first

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Verhuur en exploitatie van eigen of geleasd niet-residentieel onroerend goed, exclusief terreinen68203Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen68203Handel in eigen onroerend goed68100Handel in eigen onroerend goed68110Handel in onroerend goed70120
Primary activity highlighted.
Names & trade names
Legal nameNL PEGATRIM
Registered office
Marnixlaan 23
1000 Brussel, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.